ChengDa Pharmaceuticals Co. Ltd. (301201) — Free Cash Flow Generation Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Free Cash Flow Generation Index of -9.00x as of December 2024. Free cash flow of CN¥-257.72 Million represents -9% of operating cash flow (CN¥28.65 Million). Read ChengDa Pharmaceuticals Co. Ltd. total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for ChengDa Pharmaceuticals Co. Ltd. across 6 annual periods. Explore 301201 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for ChengDa Pharmaceuticals Co. Ltd.. For the full company profile including market capitalisation, see 301201 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -9.00x | CN¥-257.72 Million | CN¥28.65 Million | CN¥286.36 Million | ▼ -5200.6% |
| 2023 | -0.17x | CN¥-32.60 Million | CN¥192.07 Million | CN¥224.67 Million | ▲ +94.9% |
| 2022 | -3.32x | CN¥-158.03 Million | CN¥47.67 Million | CN¥205.69 Million | ▼ -396.1% |
| 2021 | -0.67x | CN¥-55.56 Million | CN¥83.14 Million | CN¥138.70 Million | ▼ -232.3% |
| 2020 | 0.51x | CN¥65.16 Million | CN¥128.97 Million | CN¥63.81 Million | ▲ +107.2% |
| 2019 | 0.24x | CN¥16.46 Million | CN¥67.52 Million | CN¥51.06 Million | — |